CRCM LP’s Mead Johnson Nutrition Company MJN Stock Holding History

CRCM LP’s Portfolio MJN Stock Details MJN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-61,000	Closed	-$4.83M	–	8
2013 Q2	$4.83M	Buy	+61,000	New	+$4.89M	12.3%	4

Other funds holding MJN

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

CRCM LP's MJN Position: Q3 2013 in Review

CRCM LP sold out of Mead Johnson Nutrition Company (MJN) in Q3 2013, closing a stake of 61,000 shares — an estimated $4.83M sold.

CRCM LP first reported a position in MJN in Q2 2013 and held it in 1 quarter. The position peaked at $4.83M in Q2 2013. 450 funds tracked by Wall St. Rank hold MJN as of Q3 2013.

CRCM LP reported no remaining Mead Johnson Nutrition Company position as of Q3 2013 after selling out during the quarter.
CRCM LP sold 61,000 Mead Johnson Nutrition Company shares in Q3 2013, an estimated $4.83M.
CRCM LP first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 1 quarter.
CRCM LP's Mead Johnson Nutrition Company position peaked at $4.83M in Q2 2013.
450 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q3 2013.

Based on CRCM LP's 13F filing for Q3 2013, filed 13 Nov 2013.